Chain industry is alive and well: NACDS profile

Article

In 2003, more than 3.2 billion prescriptions were filled; that's an increase of more than 65% since 1992. This good news comes from the National Association of Chain Drug Stores Foundation's recently released 2004 Chain Pharmacy Industry Profile.

Recent Videos
Related Content
Q&A: Pharmacists’ Role in Helping Patients Manage Ultra-High-Cost Drugs

Q&A: Pharmacists’ Role in Helping Patients Manage Ultra-High-Cost Drugs

Brian Nowosielski;Erin R. Fox, PharmD, MHA, BCPS, FASHP
February 3rd 2025
Article

Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to explore ultra-high-cost drugs and pharmacists’ role in managing patients’ prescription regimens.

pharmacist and patient

Reach Your Business Goals in 2021

Jennifer Barrett
March 25th 2021
Podcast

In part 1 of our podcast series with American Associated Pharmacies (AAP), AAP President and CEO Jon Copeland dives into key pharmacy industry trends.

Q&A: The Rise of AI in Alleviating Health Care Workforce Challenges

Q&A: The Rise of AI in Alleviating Health Care Workforce Challenges

Brian Nowosielski;Scott Nelson, PharmD, MS, FAMIA, ACHIP
January 29th 2025
Article

Scott Nelson, PharmD, MS, FAMIA, ACHIP, discussed the increasingly crucial role artificial intelligence has played in streamlining pharmacy services.

Over the Counter podcast

ThoughtSpot Series: Closing the Healthcare Gap

January 7th 2021
Podcast

Our final episode in our ThoughtSpot 2020 podcast series features NPhA president Dr. Ryan Marable and immediate past president Dr. Lakesha Butler, who share insights on health disparities and the social determinants of health.

Q&A: Pharmacists’ Play Key Role in Alleviating Primary Care Gap

Q&A: Pharmacists’ Play Key Role in Alleviating Primary Care Gap

Brian Nowosielski;Jonathan Watanabe, PharmD, MS, PhD, BCGP
January 24th 2025
Article

Jonathan Watanabe, PharmD, MS, PhD, BCGP, joined Drug Topics to discuss how pharmacists can facilitate improved patient outcomes through collaborative care.

Q&A: Ultra-High-Cost Drugs Highlight Complex US Health Care System

Q&A: Ultra-High-Cost Drugs Highlight Complex US Health Care System

Brian Nowosielski;Erin R. Fox, PharmD, MHA, BCPS, FASHP
January 22nd 2025
Article

Erin Fox, PharmD, MHA, BCPS, FASHP, discussed the 2025 Pharmacy Forecast and its perspective on managing ultra-high-cost drugs.

© 2025 MJH Life Sciences

All rights reserved.